Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Revenue

In the year 2025, Tianjin TEDA Biomedical Engineering Company had annual revenue of 522.97M CNY with 35.67% growth. Tianjin TEDA Biomedical Engineering Company had revenue of 226.41M in the half year ending June 30, 2025, with 21.78% growth.

• Revenue: 522.97M CNY
• Revenue Growth: +35.67%
• P/S Ratio: 1.06
• Revenue / Employee: 2.01M CNY
• Employees: 260
• Market Cap: 618.83M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	522.97M	137.48M	35.67%
Dec 31, 2024	385.48M	-12.52M	-3.14%
Dec 31, 2023	398.00M	-5.73M	-1.42%
Dec 31, 2022	403.73M	-72.66M	-15.25%
Dec 31, 2021	476.38M	107.03M	28.98%